Susceptibility of Feline Immunodeficiency Virus/Human Immunodeficiency Virus Type 1 Reverse Transcriptase Chimeras to Non-Nucleoside RT Inhibitors

Johan Auwerx; Robert Esnouf; De Clercq Erik; Jan Balzarini

doi:10.1124/mol.65.1.244

Back

Susceptibility of Feline Immunodeficiency Virus/Human Immunodeficiency Virus Type 1 Reverse Transcriptase Chimeras to Non-Nucleoside RT Inhibitors

Article 2004 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Construction of chimeric feline immunodeficiency virus reverse transcriptase to map its lack of susceptibility to non-nucleoside reverse transcriptase inhibitors

Johan Auwerx, Robert Esnouf, De Clercq Erik, Jan Balzarini

Article1993

Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.

Zeger Debyser, K De Vreese, P P Knops-Gerrits, Veerle Baekelandt, Ramagauri Bhikhabhai, B. Strandberg, Rudi Pauwels, Jozef Anné, Jan Desmyter, De Clercq Erik

Article1994

Sensitivity of (138 Glu → Lys) Mutated Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase (RT) to HIV-1-Specific RT Inhibitors

Jan Balzarini, J. Kleim, G Riess, Marı́a-José Camarasa, De Clercq Erik, Anna Karlsson

Article1991

Chemotherapy of the acquired immune deficiency syndrome (AIDS): Non-nucleoside inhibitors of the human immunodeficiency virus type 1 reverse transcriptase

De Clercq Erik

Article1996

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: Strategies to overcome drug resistance development

De Clercq Erik